{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:26:46Z","timestamp":1793608006141,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008040","name":"Kao Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129111","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:32:03Z","timestamp":1788589923000},"page":"129111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Improving intradermal dosing consistency in mice using a hollow microneedle: A model study with a SARS-CoV-2 mRNA vaccine"],"prefix":"10.1016","volume":"92","author":[{"given":"Shintaro","family":"Onishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Shiiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Niitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Hariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129111_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081811","article-title":"The dynamics of the skin\u2019s immune system","volume":"20","author":"Nguyen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vaccine.2026.129111_bb0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41385-022-00505-y","article-title":"Skin immunity: dissecting the complex biology of our body\u2019s outer barrier","volume":"15","author":"Zhang","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.vaccine.2026.129111_bb0015","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.vaccine.2026.129111_bb0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.vaccine.2026.129111_bb0025","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","article-title":"Serum antibody responses after intradermal vaccination against influenza","volume":"351","author":"Belshe","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2026.129111_bb0030","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1016\/j.vaccine.2015.09.051","article-title":"A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination","volume":"33","author":"David","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129111_bb0035","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vaccine.2026.129111_bb0040","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.2182","article-title":"Dissolving polymer microneedle patches for influenza vaccination","volume":"16","author":"Sullivan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.vaccine.2026.129111_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114263","article-title":"Development of a dissolving microneedle patch for transdermal delivery of SARS-CoV-2 mRNA vaccine with enhanced stability and immunogenicity","volume":"388","author":"Tang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vaccine.2026.129111_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113944","article-title":"Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle array patch delivery","volume":"384","author":"Driskill","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vaccine.2026.129111_bb0055","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1016\/j.vaccine.2021.10.043","article-title":"Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine","volume":"39","author":"Fan","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129111_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4161\/hv.22342","article-title":"Intanza (\u00ae) 9 \u03bcg intradermal seasonal influenza vaccine for adults 18 to 59 years of age","volume":"9","author":"Leroux-Roels","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.vaccine.2026.129111_bb0065","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.vaccine.2012.02.003","article-title":"Intanza(\u00ae) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses","volume":"30","author":"Ansaldi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129111_bb0070","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.vaccine.2010.06.062","article-title":"Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults","volume":"28","author":"Laurent","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129111_bb0075","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.vaccine.2021.12.061","article-title":"Performance and usability evaluation of novel intradermal injection device Immucise\u2122 and reanalysis of intradermal administration trials of influenza vaccine for the elderly","volume":"40","author":"Shimizu","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129111_bb0080","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/j.vaccine.2023.06.028","article-title":"Preclinical evaluation of performance, safety and usability of VAX-ID\u00ae, a novel intradermal injection device","volume":"41","author":"Beyers","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129111_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2017.09.021","article-title":"Intradermal vaccination with hollow microneedles: a comparative study of various protein antigen and adjuvant encapsulated nanoparticles","volume":"266","author":"Du","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vaccine.2026.129111_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11095-018-2476-4","article-title":"Coated and hollow microneedle-mediated intradermal immunization in mice with diphtheria toxoid loaded mesoporous silica nanoparticles","volume":"35","author":"Du","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.vaccine.2026.129111_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2017.11.035","article-title":"Hollow microneedle-mediated micro-injections of a liposomal HPV E7(43-63) synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responses","volume":"269","author":"van der Maaden","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vaccine.2026.129111_bb0100","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11095-024-03681-7","article-title":"A hollow microneedle equipped with a micropillar for improved needle insertion and injection of drug solution","volume":"41","author":"Futaki","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.vaccine.2026.129111_bb0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.129111_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vaccine.2026.129111_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8030534","article-title":"Vaccination into the dermal compartment: techniques, challenges, and prospects","volume":"8","author":"Hettinga","year":"2020","journal-title":"Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:36:00Z","timestamp":1793604960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S0264410X26009205"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129111","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving intradermal dosing consistency in mice using a hollow microneedle: A model study with a SARS-CoV-2 mRNA vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129111"}}